RGC (regencellbioscience.com) Kompaniyaning sof daromadi

RGC (regencellbioscience.com) - kompaniyaning tovar belgisi

Regencell Bioscience (RGC) kompaniyasining foydalanish darajasi past bo'lgan ideal laboratoriyalar faoliyatiga asoslangan joriy foydasi -0.01 darajasida to'xtab qoldi. Regencell Bioscience bolalar salomatligi xavfsizligiga e'tibor qaratgan holda, neyromeditsina innovatori sifatida imidjini shakllantirmoqda. Biroq, uning sinov bosqichidagi biotexnologiya kompaniyasi maqomi daromadlar yo'qligini va muntazam yo'qotishlarni kafolatlaydi, bu esa pul oqimlarini oldindan aytib bo'lmaydigan qiladi va doimiy tashqi moliyalashtirishni taqozo etadi.

RGC Regencell Bioscience Holdings Limited: Sof foyda 04.07.2022 - 29.10.2026 oraligʻida

Regencell Bioscience Holdings Limited (RGC) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va konsensus maqsadli narx:
Narxlar dinamikasi grafigi Regencell Corp|RGC - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor qiymati Regencell Corp|RGC - Korxona qiymati
- balans bo'yicha xususiy kapital ma'lumotlari:
Yagona aksiya balans qiymati Regencell Bioscience|RGC - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti regencellbioscience.com|RGC - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Regencell Bioscience|RGC - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Regencell Bioscience Ltd|RGC - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Regencell Corp|RGC - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Regencell Bioscience|Tezkor likvidlik regencellbioscience.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
RGC - Sof daromad
Fundamental baholash:RGC Regencell Corp
Regencell brendining mahsuloti

Ushbu ko'rsatkich sof foydaning uzluksiz monitoringini ta'minlaydi, bunda egri chiziq dinamikasi biznesdagi barqaror operatsion bosqichlarni kritik tarkibiy nosozliklardan farqlash imkonini beradi. Regencell Bioscience (RGC) taqsimlanadigan foydasining tahlili klinik sinovlar bosqichi tufayli tijorat daromadlarining yo'qligini tasdiqlaydi, bu esa dori vositalari bozorga chiqarilgunga qadar ushbu grafikni sof kapital sarfining aksiga aylantiradi.

Asosiy raqobatchilar

Biogen Idec - Yakuniy foyda|NBIX (Neurocrine Biosciences) - Sof foyda|Kompaniyaning sof daromadi axsome.com AXSM|Sof foyda ACAD|Xenon Pharmaceuticals Inc. (XENE) - Yillik sof foyda|Sof foyda VKTX (Viking Pharma)|Supernus Corp (SUPN) - Kompaniyaning sof daromadi|CPRX - Kompaniyaning sof foydasi|DNLI (denalitherapeutics.com) - Kompaniya foydasi|HRMY: Sof foyda|Sof daromad Biohaven Ltd|AMLX (Amylyx) - Sof foyda|Kompaniyaning sof daromadi Trevi Corp TRVI|Kompaniyaning sof foydasi Praxis Precision Medicines (PRAX)|Kompaniyaning sof foydasi AVXL (anavex.com)|Kompaniyaning sof foydasi CeriBell CBLL|Prothena Corp - Kompaniyaning sof foydasi|ALEC: Sof daromad|Yakuniy foyda ANNX (Annexon Biosciences Inc.)|OMER: Sof foyda|NGNE (neurogene.com) - Kompaniyaning sof foydasi|ACIU (AC Immune SA) - Sof foyda|Voyager Therapeutics Inc (VYGR) - Sof moliyaviy natija|Kompaniyaning sof foydasi Neumora Therapeutics Inc (NMRA)|SCLX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Tevogen Bio Holdings TVGN|Sof moliyaviy natija Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Sof foyda|Inhibikase Therapeutics Inc (IKT) - Sof daromad|SAVA: Sof foyda|ASRT - Sof moliyaviy natija|COYA (Coya Therapeutics Inc) - Sof foyda|Kompaniyaning sof daromadi VistaGen Therapeutics Inc VTGN|Kompaniyaning sof foydasi Ovid Therapeutics Inc. (OVID)|Acumen Pharmaceuticals Inc. - Kompaniya foydasi|Sof foyda CRVO (CervoMed Inc)|ATHE - Sof daromad|Clene Nanomedicine - Sof foyda|Kompaniyaning sof daromadi PepGen Inc.|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|Relmada Therapeutics Inc - Yakuniy foyda|ANVS (Annovis Bio Corp) - Sof foyda|GRCE - Yillik sof foyda|Sof foyda AIFF|Sof daromad anewmeds.com KLTO|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|RVPH: Kompaniya foydasi|MetaVia, Inc. - Sof foyda|Kompaniyaning sof daromadi NeurAxis Inc|HSDT (heliusmedical.com) - Sof daromad|Passage Bio (PASG) - Sof foyda|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|NERV: Yakuniy foyda|Kompaniyaning sof foydasi Athira (ATHA)|ADXN - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Yakuniy foyda CYCN|Protagenic - Sof foyda|Kompaniyaning sof daromadi Pasithea Therapeutics|CRGT: Sof foyda|Yillik sof foyda Avenue Therapeutics Inc ATXI|BCLI (Brainstorm Cell) - Sof foyda|Kompaniyaning sof daromadi caratherapeutics.com CARA|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Kompaniya foydasi|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|LBPH - Sof daromad|Marinus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|SAGE (Sage Therapeutics Inc.) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Neurotrope|Kompaniyaning sof foydasi TRVN|Sof daromad VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Yakuniy foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)